CALC

CalciMedica, Inc. Common Stock

CALC.US calcimedica.com + Research + Basket
CIK 0001534133
Employees 15
Phone 858 952 5500
Fiscal year end December
IPO Sep 25, 2020
Address 505 Coast Boulevard South, La Jolla, CA, United States, 92037
1.30
-0.05 (-3.35%)
USD · NASDAQ
52-week range
1.00
36.00
Trading at 1% of the 52-week range
Market Cap
8.88M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
0.90
Div. Yield
N/A
% Institutions
57.32%
% Insiders
18.53%

1 Year

-91.2%

3 Year

-91.9%

10 Year

-99.4%
Description

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.

Actions

Add an action for CALC.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. A. Rachel Leheny Ph.D. CEO & Director 1963
Mr. Eric W. Roberts Chief Business Officer & Vice Chairman of the Board 1964
Dr. Sudarshan Hebbar M.D. Chief Medical Officer 1966
Mr. Michael J. Dunn B.A., M.B.A. President & COO 1956
Dr. Anjana Rao Ph.D. Co-Founder and Scientific Advisor NA
Dr. Patrick Hogan Ph.D. Co-Founder and Scientific Advisor NA
Dr. Stefan Feske M.D. Co-Founder and Scientific Advisor NA
Dr. Kenneth A. Stauderman Ph.D. Co-Founder & Chief Scientific Officer 1954
Mr. John M. Dunn J.D. General Counsel 1952

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Sep 18, 2025 Eric W Roberts N/A Purchase 2.50K $3.07 $7.68K SEC
Sep 15, 2025 Eric W Roberts N/A Purchase 3.40K $2.68 $9.11K SEC
Sep 12, 2025 Eric W Roberts N/A Purchase 5.00K $3.12 $15.60K SEC
Sep 09, 2025 Eric W Roberts N/A Purchase 2.34K $3.15 $7.38K SEC
Aug 29, 2025 Eric W Roberts N/A Purchase 800.00 $2.74 $2.19K SEC
Aug 28, 2025 Eric W Roberts N/A Purchase 9.20K $2.86 $26.31K SEC
Aug 21, 2025 Eric W Roberts N/A Purchase 3.51K $2.79 $9.79K SEC
Aug 20, 2025 Eric W Roberts N/A Purchase 2.00K $2.72 $5.44K SEC
Aug 19, 2025 Eric W Roberts N/A Purchase 1.00K $2.79 $2.79K SEC
Aug 19, 2025 Sudarshan Hebbar N/A Purchase 9.56K $2.82 $26.97K SEC
Aug 15, 2025 Eric W Roberts N/A Purchase 5.08K $2.90 $14.72K SEC
Aug 15, 2025 Sudarshan Hebbar N/A Purchase 4.39K $2.79 $12.25K SEC
Aug 14, 2025 Sudarshan Hebbar N/A Purchase 1.58K $2.58 $4.09K SEC
Jul 28, 2025 Kenneth A Stauderman N/A Purchase 1.00K $3.96 $3.96K SEC
Jul 25, 2025 Kenneth A Stauderman N/A Sale 1.00K $3.65 $3.65K SEC
Jul 21, 2025 A. Rachel Leheny N/A Purchase 1.00K $3.40 $3.40K SEC
Jul 21, 2025 Eric W Roberts N/A Purchase 1.50K $3.37 $5.06K SEC
Jul 18, 2025 Eric W Roberts N/A Purchase 2.00K $2.88 $5.76K SEC
Jul 18, 2025 Robert N Wilson N/A Purchase 4.50K $2.87 $12.92K SEC
Jul 14, 2025 A. Rachel Leheny N/A Purchase 2.50K $2.47 $6.18K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Woodline Partners LP 2.49M Jun 30, 2026 7.29% $0.01 0.00%
Heights Capital Management Inc 1.56M Jun 30, 2026 4.56% $0.37 0.00%
StemPoint Capital LP 1.24M Jun 30, 2026 3.65% $0.21 0.00%
Squadron Capital Management LLC 1.24M Jun 30, 2026 3.65% $0.40 0.00%
Stonepine Capital Management Llc 622.43K Jun 30, 2026 1.82% $0.31 0.00%
L1 Global Manager Pty Ltd 248.97K Jun 30, 2026 0.73% $0.18 0.00%
Morgan Stanley - Brokerage Accounts 143.25K Jun 30, 2026 0.42% $0.00 0.00%
CAMBRIDGE Invest RESEARCH ADVISORS, INC. 120.00K Jun 30, 2026 0.35% $0.00 100.00%
Geode Capital Management, LLC 110.48K Jun 30, 2026 0.32% $0.00 -10.46%
Renaissance Technologies Corp 97.30K Jun 30, 2026 0.29% $0.00 -24.03%
Vanguard Capital Management, LLC 88.96K Jun 30, 2026 0.26% $0.00 -47.40%
180 WEALTH ADVISORS, LLC 83.40K Jun 30, 2026 0.24% $0.01 -34.07%
XTX Topco Ltd 78.29K Jun 30, 2026 0.23% $0.00 0.00%
HRT FINANCIAL LLC 46.83K Jun 30, 2026 0.14% $0.00 17.95%
Vanguard Fiduciary Trust Co 45.83K Jun 30, 2026 0.13% $0.00 0.00%
Susquehanna International Group, LLP 43.97K Jun 30, 2026 0.13% $0.00 43.14%
Rockefeller Capital Management L.P. 20.00K Jun 30, 2026 0.06% $0.00 300.00%
GSA Capital Partners LLP 17.47K Jun 30, 2026 0.05% $0.00 -26.53%
State Street Corp 17.07K Jun 30, 2026 0.05% $0.00 0.00%
TritonPoint Partners, LLC 15.12K Jun 30, 2026 0.04% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Abante Quant Value FI 28.28K 0.08% ▲ 105.85% Aug 31, 2026
2 Fidelity Extended Market Index 13.29K 0.04% ▲ 32.66% Aug 31, 2026
3 Fidelity Nasdaq Composite Index 3.27K 0.01% ▲ 0.00% Aug 31, 2026
4 Fidelity Series Total Market Index 2.48K 0.01% ▲ 0.00% Aug 31, 2026
5 Fidelity Total Market Index 2.34K 0.01% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $8.88M
EBITDA: $-19.60M
Book Value: $0.90
Earnings/Share: $-6.54
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -63.58%
ROE (TTM): -365.70%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $484.02K
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 6.83M
Shares Float: 3.79M
% Insiders: 18.53%
% Institutions: 57.32%
Shares Short: 61.64K
Shares Short (Prior Month): 86.43K
Short Ratio: 0.95
Short % Float: 1.63%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-46.00K
Gross Profit
subtotal
$-46.00K
SG&A
adjust
$-7.89M
R&D
adjust
$-15.23M
Operating Income
subtotal
$-23.12M
Other / Non-Operating Items
adjust
$-6.44M
Net Income
subtotal
$-29.56M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CALC.US!